NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice
Sam Tsimikas/X
Aug 23, 2025, 08:14

Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice

Sam Tsimikas, Professor of Medicine at the University of California, San Diego, shared a post on X:

“A new paper is out in Lipid Journal validating the NAFCS score for patients with FCS (Familial Chylomicronemia Syndrome- i.e milky plasma) using the Balance genetic data. It will be an alternative method to make the diagnosis of FCS clinically.”

Read the full paper here.

Article: Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study

Authors: Alan S. Brown, Philippe Moulin, Andrew Dibble, Veronica J. Alexander, Lu Li, Daniel Gaudet, Joseph L. Witztum, Sotirios Tsimikas, Robert A.

Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice

Stay updated with Hemostasis Today.

 

Alan S. Brown Andrew Dibble Cardiometabolic Health Chylomicronemia Syndrome Clinical Validation Daniel Gaudet FCS Genetic Diagnosis Health Hematology Hemostasis Today Joseph L. Witztum Lipid Research LipidJournal Lu Li Medicine NAFCS Philippe Moulin Rare Disorders Robert A. Sotirios Tsimikas Veronica J. Alexander
NewsFeed